4.7 Article

Synthesis of Novel Tricyclic Chromenone-Based Inhibitors of IRE-1 RNase Activity

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 57, Issue 10, Pages 4289-4301

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm5002452

Keywords

-

Funding

  1. National Institutes of Health [R01CA163910]
  2. American Cancer Society [IRG9309214, IRG9303216]
  3. Moffitt Team Science award
  4. Miles for Moffitt Foundation

Ask authors/readers for more resources

Inositol-requiring enzyme 1 (IRE-1) is a kinase/RNase ER stress sensor that is activated in response to excessive accumulation of unfolded proteins, hypoxic conditions, calcium imbalance, and other stress stimuli. Activation of IRE-1 RNase function exerts a cytoprotective effect and has been implicated in the progression of cancer via increased expression of the transcription factor XBP-1s. Here, we describe the synthesis and biological evaluation of novel chromenone-based covalent inhibitors of IRE-1. Preparation of a family of 8-formyltetrahydrochromeno[3,4-c]pyridines was achieved via a Duff formylation that is attended by an unusual cyclization reaction. Biological evaluation in vitro and in whole cells led to the identification of 30 as a potent inhibitor of IRE-1 RNase activity and XBP-1s expression in wild type B cells and human mantle cell lymphoma cell lines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available